Quipt Home Medical Corp T.QIPT

Alternate Symbol(s): QIPT

Healthcare

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.

TSX:QIPT - Post by User

Quipt Home Medical Corp > Not a "move the needle acquisition"

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Aug 23, 2021 5:21pm

115 Views

Post# 33751111

RE:Not a "move the needle acquisition"

These small tuck-ins are even better. Add $5 million by acquistion and then they double their revenue organically in < 1 year.

besttobe wrote: Only up 2.7%. Some of that gain, may have been traders buying before earnings. So now we wait for Q release. I don't expect much.

The CC should be interesting given the philips recall, chip shortage, 4th covid wave , tight labor market etc etc....

Will see if there is any type of trade after that.

GLTA

PS..Raman1- You are only 5000 patients off your 150K patient target. I am not sure 5000 more patients is going to cut it for you. They need alot more than that, before they become profitable. They need a large acquisition as tuckins/quarterly losses and cash burn have put the market to sleep. IMO.